trade agreements

Policy discussions and actions related to the COVID-19 pandemic

Below we’ve provided a round-up of recent developments related to the COVID-19 pandemic. Policymakers are working to identify and execute the best policies for pandemic preparedness and healthcare delivery, against a difficult backdrop. Innovators and other actors must step forward to provide their insights and experiences on the ground, whether in relation to IP, trade, regulatory or other types of policies.

African Union backs call to waive IP rights on COVID-19 drugs

The African Union is backing calls for drugmakers to waive some intellectual property rights on COVID-19 medicines and vaccines to speed up their rollout to poor countries.

Read the full story.

Senator calls on Biden to reject COVID IP waiver

Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation (WTO).

Read the full story.

U.S. Chamber opposes WTO waiver of vaccine intellectual property rights

The U.S. Chamber of Commerce said it opposed calls for the World Trade Organization to back a temporary waiver of intellectual property rights to speed coronavirus vaccine production in poor countries, calling them “misguided”.

Read the full story.

U.S. Extends Tariff Exclusion on China Virus Supplies 6 Months

The U.S. is extending exclusions on tariffs for face masks, cleaning supplies and other personal protective equipment from China for six months, providing protection against higher costs as the nation fights the Covid-19 pandemic.

The move affects 99 different products, according to a draft of the notice by the U.S. Trade Representative seen by Bloomberg News. The exclusions, extended in December, will now run through the end of September 2021.

Read the full story.

UNCTAD Paper Examines Linkages Between Non-Tariff Measures and SDGs

According to this paper, of all the NTMs adopted in response to the pandemic, almost 60 per cent were put in place to ensure adequate and affordable domestic supplies of medical goods and other essential items to combat the virus.

To minimize potential adverse impacts on trade and sustainability, the paper recommends policymakers first consider whether an NTM is needed or whether there are alternatives, then design high-quality NTMs where they are needed and implement them strategically with full transparency to inform other countries and the private sector of the measure.

Read the full story.

EU-UK Trade and Cooperation Agreement: Implications for Life Sciences Companies

The widely anticipated EU-UK Trade and Cooperation Agreement (the Agreement) came into effect on 1 January 2021 after several difficult months of negotiations. The Agreement aims to ease trade barriers resulting from the UK leaving the EU and includes positive developments for life sciences companies. However, according to this article, the Agreement does not address all of the concerns raised by the life sciences industry, and significant gaps and areas for further discussion remain between the EU and the UK as the Agreement is implemented. This Client Alert from 03 March 2021 sets out key aspects of the Agreement for life sciences companies.

Read the full story.

 

View Project

Bio-Pharmaceutical Manufacturing and R&D: The Impact of Policy Coherence in Trade Policy

This Innovation Council working paper illustrates the importance of policy coherence in the realm of biopharmaceutical manufacturing and R&D. Specifically, it shows that investing in diversified, geographically dispersed sources of R&D and production can increase manufacturing capacity and strengthen health security by complementing existing pharmaceutical production chains, thus making them less vulnerable to future supply chain shocks. It shows that counterproductive trade measures, such as tariffs on the development and production of vaccines and other health technologies, can slow development, and that—especially in light of the experience of Covid-19—distributed manufacturing and R&D capabilities are particularly useful in the area of biopharmaceuticals.

View Project

Trade in the time of pandemics

Ngozi Okonjo-Iweala, the first female and first African leader of the World Trade Organization (WTO) argues why trade will help us find a way out of the pandemic with borders closed and global travel constrained.

The multilateral trading system is fundamental to fighting the current COVID-19 pandemic, preparing for future pandemics, and stimulating the global economic recovery. Trade barriers distort markets and create an uneven playing field, with the potential to reduce production when increased supplies are needed. To ensure that the multilateral trading system works smoothly and flexibly during a moment of global crisis, the WTO should play a more active facilitation role. It should work in close partnership with other relevant international organizations such as WHO, COVAX and the International Finance Institutions (IFIs) — to provide solutions to the pandemic.

Read the full story.

View Project

Expectations rise for China-US health cooperation

In their 2021 annual letter themed ‘the year global health went local’ released by Bill Gates and Melinda Gates, they are reviewing the epidemic in 2020 and addressing the future.

Gates stressed that cooperation between China and the US is critical to combating the pandemic, including ending the current pandemic and preventing the next one, while he pointed to China’s continuing technological advances, improving regulatory capabilities and a growing willingness to help the world.

Roberta Lipson, founder of United Family Healthcare, agreed that there is plenty of room for cooperation between China and the US, first and foremost in healthcare amid the epidemic’s hardships. High tariffs make the use of imported products more costly for both countries, said Lipson, adding that elimination or reduction of these duties would give patients in both countries access to the most suitable products at reduced costs.

“Opening the market for leading-edge therapies and medicines will also benefit from level playing fields in central procurement as well as reliable intellectual property rights protection,” said Lipson.

Read the full story.

View Project

Semiconductors & the WTO

This report by the Semiconductor Industry Association argues that the steady opening of markets and leveling of the global playing field spearheaded by the WTO over the past 25 years has been critical to the success of the global semiconductor industry. Given the sheer volume and complexity of global semiconductor trade, along with high capital costs and short product life-cycles, the ability to move semiconductor goods and materials freely, fairly, and efficiently across borders has been critical to the industry’s success and technological progress.

View Project

Vaccine manufacturing and distribution: WTO perspectives

Around the world, multiple vaccines against COVID-19 are on track for regulatory approval. Arriving at safe, efficacious vaccines of consistent quality will be a major scientific achievement. No less a feat will be manufacturing and delivering COVID-19 vaccines globally – a challenge of unparalleled scale, reach, and complexity. This checklist from the WTO breaks down the regulatory, IP-related, and trade-related concerns that must be considered at each step, from development to distribution. This accompanying infographic illustrates these steps visually.

View Project

Celebration of WTO’s 25th Anniversary

On the occasion of the WTO’s 25th anniversary, a number of representatives of the private sector, international organizations and non-governmental organizations have provided video messages where they reflect on what the WTO and the multilateral trading system means to them. They provide their thoughts on how to ensure trade continues to support economic growth, development and job creation and what they expect from the global trading system in the future.

View Project

Virtual symposium to mark 25 years of the TRIPS Agreement

The WTO is organizing on 24 November 2020 a virtual symposium to mark the 25th Anniversary of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). This will be the first of a series of commemorative events reflecting on the impact and evolution of the most comprehensive multilateral treaty on intellectual property protection and enforcement.

View Project

Singaporean business associations welcome RCEP

Two Singaporean business associations, the Association of Small and Medium Enterprises and the Singapore Chinese Chamber of Commerce and Industry, have welcomed the signing of the Regional Comprehensive Economic Partnership (RCEP), and said they will help local small and medium enterprises tap into the opportunities provided by the agreement.

The RCEP was signed by the ten ASEAN states (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam), and five of their FTA partners—Australia, China, Japan, New Zealand, and South Korea. The 15 member countries account for 30% of the world’s population and 30% of global GDP, making it the world’s largest trade bloc.

View Project